The estimated Net Worth of Eugene Cordes is at least $5.79 Million dollars as of 17 March 2011. Eugene Cordes owns over 2,000 units of Vertex Pharmaceuticals stock worth over $5,696,880 and over the last 19 years Eugene sold VRTX stock worth over $89,240.
Eugene has made over 1 trades of the Vertex Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently Eugene sold 2,000 units of VRTX stock worth $89,240 on 17 March 2011.
The largest trade Eugene's ever made was selling 2,000 units of Vertex Pharmaceuticals stock on 17 March 2011 worth over $89,240. On average, Eugene trades about 222 units every 0 days since 2005. As of 17 March 2011 Eugene still owns at least 12,000 units of Vertex Pharmaceuticals stock.
You can see the complete history of Eugene Cordes stock trades at the bottom of the page.
Eugene's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: